Topics: Veterinary medicine

Christian Hedberg is developing a new treatment of cryptosporidiosis and is working closely with Umeå Biotech Incubator to bring the treatment to the market. PHOTO: Mattias Pettersson/Umeå University

New UBI Case Aims to Revolutionize Treatment of Cryptosporidiosis

Christian Hedberg, a professor at Umeå University, is developing a revolutionary drug to treat cryptosporidiosis in animals and humans. He collaborates with France's INRAE and the treatment has shown promising results in ruminant models and has the potential to address a significant global health issue. Christian Hedberg has joined Umeå Biotech Incubator to bring the treatment to the market.

We grow ideas that can change the world

Umeå Biotech Incubator (UBI) is one of Sweden’s state-of-the-art business incubators within the life sciences. We help researchers to use their data to the benefit of patients and citizens, improving their health. We support and train entrepreneurs in the fields of pharmaceuticals, diagnostics and medical engineering, and act as a bridge between academia, medicine and the business community.

Umeå Biotech Incubator
Umeå Biotech Incubator

Tvistevägen 48C
907 36 Umeå
Sweden

ubi.se
Umeå Biotech Incubator Enter your email address to follow Umeå Biotech Incubator

When you choose to create a user account and follow a newsroom your personal data will be used by us and the owner of the newsroom, for you to receive news and updates according to your subscription settings.

To learn more about this, please read our Privacy Policy, which applies to our use of your personal data, and our Privacy Policy for Contacts, which applies to the use of your personal data by the owner of the newsroom you follow.

Please note that our Terms of Use apply to all use of our services.

You can withdraw your consent at any time by unsubscribing or deleting your account.
Umeå Biotech Incubator Check your inbox

Email sent to __email__. Click the link there to follow Umeå Biotech Incubator.

Okay